 Phase: Phase IIIType: TreatmentStatus: ActiveAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: 1199.52, 2012-000095-42, NCT02149108Phase: Phase IIType: TreatmentStatus: ActiveAge: 18 and overSponsor: NCIProtocol IDs: CDR0000666736, ECOG-E7208, E7208, NCT01079780Phase: Phase IIType: TreatmentStatus: ActiveAge: 18 and overSponsor: OtherProtocol IDs: 2012-0776, NCI-2013-00077, NCT01730586Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: ActiveAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: B2151007, 2013-002096-18, NCT01937715 